Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern by Hadas Cohen-Dvashi, Jonathan Weinstein, Michael Katz, Maayan Eilon-Ashkenazy, Yuval Mor, Amir Shimon, Hagit Achdout, Hadas Tamir, Tomer Israely, Romano Strobelt, Maya Shemesh, Liat Stoler-Barak, Ziv Shulman, Nir Paran, Sarel Jacob Fleishman, Ron Diskin

Get full text